Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: Role in inflammation and autoimmunity

Journal of Interferon and Cytokine Research

Volumn 30, Issue 6, 2010, Pages 371-380

  Choubey, Divaker ^a,b   Duan, Xin ^a   Dickerson, Eric ^a   Ponomareva, Larissa ^a,b   Panchanathan, Ravichandran ^a,b   Shen, Hui ^a,b   Srivastava, Ratika ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXTRACHROMOSOMAL DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERFERON; MELANOMA ANTIGEN 2; PROTEIN P200; PYRINDAMYCIN A; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CHRONIC INFLAMMATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; REVIEW; SEQUENCE ALIGNMENT;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; HUMANS; INFLAMMATION; MICE; NUCLEAR PROTEINS;

MURINAE; MUS;

EID: 77953583256     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0096     Document Type: Review

References (83)

1. Albrecht M, Choubey D, Lengauer T. 2005. The HIN domain of IFI-200 proteins consists of two OB folds. Biochem Biophys Res Commun 327 ( 3 ): 679-687.
2. Aravind L, Dixit VM, Koonin EV. 2001. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 291 ( 5507 ): 1279-1284.
3. Asefa B, Klarmann KD, Copeland NG, Gilbert DJ, Jenkins NA, Keller JR. 2004. The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis 32 ( 1 ): 155-167.
4. Baccala R, Gonzalez-Quintial R, Lawson BR, Stern ME, Kono DH, Beutler B, Theofi lopoulos AN. 2009. Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol 5 ( 8 ): 448-456.
5. Baccala R, Hoebe K, Kono DH, Beutler B, Theofi lopoulos AN. 2007. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13 ( 5 ): 543-551.
6. Baechler EC, Gregersen PK, Behrens TW. 2004. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol 16 ( 6 ): 801-807.
7. Banchereau J, Pascual V. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25 ( 3 ): 383-392.
8. Banchereau J, Pascual V, Palucka AK. 2004. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 20 ( 5 ): 539-550.
9. Bochkarev A, Bochkareva E. 2004. From RPA to BRCA2: lessons from single-stranded DNA binding by the OB-fold. Curr Opin Struct Biol 14 ( 1 ): 36-42.
10. Bolland S, Garcia-Sastre A. 2009. Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice. J Exp Med 206 ( 8 ): 1647-1651.
11. Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, Planyavsky M, Bilban M, Colinge J, Bennett KL, Superti-Furga G. 2009. An orthogonal proteomic-genomic screen identifi es AIM2 as a cytoplasmic DNA sensor for the infl ammasome. Nat Immunol 10 ( 3 ): 266-272.
12. Chen IF, Ou-Yang F, Hung JY, Liu JC, Wang H, Wang SC, Hou MF, Hortobagyi GN, Hung MC. 2006. AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model. Mol Cancer Ther 5 ( 1 ): 1-7.
13. Choubey D. 2000. P202: an interferon-inducible negative regulator of cell growth. J Biol Regul Homeost Agents 14 ( 3 ): 187-192.
14. Choubey D. 2008. Comment on: The candidate lupus susceptibility gene Ifi 202a is largely dispensable for B-cell function. Rheumatology (Oxford) 47 ( 4 ): 558-559 ; author reply 559.
15. Choubey D, Gutterman JU. 1996. The interferon-inducible growthinhibitory p202 protein: DNA binding properties and identifi cation of a DNA binding domain. Biochem Biophys Res Commun 221 ( 2 ): 396-401.
16. Choubey D, Kotzin BL. 2002. Interferon-inducible p202 in the susceptibility to systemic lupus. Front Biosci 7: e252-e262.
17. Choubey D, Lengyel P. 1993. Interferon action: cytoplasmic and nuclear localization of the interferon-inducible 52-kD protein that is encoded by the Ifi 200 gene from the gene 200 cluster. J Interferon Res 13 ( 1 ): 43-52.
18. Choubey D, Panchanathan R. 2008. Interferon-inducible Ifi 200 -family genes in systemic lupus erythematosus. Immunol Lett 119 ( 1-2 ): 32-41.
19. Choubey D, Pramanik R, Xin H. 2003. Subcellular localization and mechanisms of nucleocytoplasmic distribution of p202, an interferon-inducible candidate for lupus susceptibility. FEBS Lett 553 ( 3 ): 245-249.
20. Choubey D, Walter S, Geng Y, Xin H. 2000. Cytoplasmic localization of the interferon-inducible protein that is encoded by the AIM2 (absent in melanoma) gene from the 200-gene family. FEBS Lett 474 ( 1 ): 38-42.
21. Cresswell KS, Clarke CJ, Jackson JT, Darcy PK, Trapani JA, Johnstone RW. 2005. Biochemical and growth regulatory activities of the HIN-200 family member and putative tumor suppressor protein, AIM2. Biochem Biophys Res Commun 326 ( 2 ): 417-424.
22. Crow MK, Wohlgemuth J. 2003. Microarray analysis of gene expression in lupus. Arthritis Res Ther 5 ( 6 ): 279-287.
23. Datta B, Li B, Choubey D, Nallur G, Lengyel P. 1996. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition. J Biol Chem 271 ( 44 ): 27544-27555.
24. Datta B, Min W, Burma S, Lengyel P. 1998. Increase in p202 expression during skeletal muscle differentiation: inhibition of MyoD protein expression and activity by p202. Mol Cell Biol 18 ( 2 ): 1074-1083.
25. Deane JA, Bolland S. 2006. Nucleic acid-sensing TLRs as modifi ers of autoimmunity. J Immunol 177 ( 10 ): 6573-6578.
26. DeYoung KL, Ray ME, Su YA, Anzick SL, Johnstone RW, Trapani JA, Meltzer PS, Trent JM. 1997. Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma. Oncogene 15 ( 4 ): 453-457.
27. Eisenbarth SC, Flavell RA. 2009. Innate instruction of adaptive immunity revisited: the infl ammasome. EMBO Mol Med 1: 92-98.
28. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. 2009. AIM2 activates the infl ammasome and cell death in response to cytoplasmic DNA. Nature 458 ( 7237 ): 509-513.
29. Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G. 2009. The infl ammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10 ( 3 ): 241-247.
30. Fridman AL, Tang L, Kulaeva OI, Ye B, Li Q, Nahhas F, Roberts PC, Land SJ, Abrams J, Tainsky MA. 2006. Expression profi ling identifi es three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton. J Gerontol A Biol Sci Med Sci 61 ( 9 ): 879-889.
31. Gribaudo G, Toniato E, Engel DA, Lengyel P. 1987. Interferons as gene activators. Characteristics of an interferon-activatable enhancer. J Biol Chem 262 ( 24 ): 11878-11883.
32. Gubbels MR, Jørgensen TN, Metzger TE, Menze K, Steele H, Flannery SA, Rozzo SJ, Kotzin BL. 2005. Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice. J Immunol 175 ( 9 ): 6190-6196.
33. Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, Watanabe T, Katagiri T, Tsunoda T, Yamaoka Y, Nakamura Y. 2002. Genomewide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 62 ( 23 ): 7012-7017.
34. Henry T, Brotcke A, Weiss DS, Thompson LJ, Monack DM. 2007. Type I interferon signaling is required for activation of the infl ammasome during Francisella infection. J Exp Med 204 ( 5 ): 987-994.
35. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating infl ammasome with ASC. Nature 458 ( 7237 ): 514-518.
36. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, Sato S, Yamamoto M, Uematsu S, Kawai T, Takeuchi O, Akira S. 2006. A Toll-like receptorindependent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7 ( 1 ): 40-48.
37. Janeway CA, Jr., Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol 20: 197-216.
38. Johnstone RW, Trapani JA. 1999. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol Cell Biol 19 ( 9 ): 5833-5838.
39. Jørgensen TN, Roper E, Thurman JM, Marrack P, Kotzin BL. 2007. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW) F(1) mice. Genes Immun 8 ( 8 ): 653-662.
40. Kanta H, Mohan C. 2009. Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplifi cation by innate immunity and end-organ infl ammation. Genes Immun 10 ( 5 ): 390-396.
41. Keith MP, Moratz C, Tsokos GC. 2007. Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease. Autoimmun Rev 6 ( 4 ): 232-236.
42. Kopp EB, Ghosh S. 1995. NF-kappa B and rel proteins in innate immunity. Adv Immunol 58: 1-27.
43. Koul D, Obeyesekere NU, Gutterman JU, Mills GB, Choubey D. 1998. p202 self-associates through a sequence conserved among the members of the 200-family proteins. FEBS Lett 438 ( 1-2 ): 21-24.
44. Krieg AM. 2009. AIMing 2 detect foreign DNA. Sci Signal 2 ( 77 ): pe39.
45. Kumagai Y, Takeuchi O, Akira S. 2008. TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev 60 ( 7 ): 795-804.
46. Landolfo S, Gariglio M, Gribaudo G, Lembo D. 1998. The Ifi 200 genes: an emerging family of IFN-inducible genes. Biochimie 80 ( 8-9 ): 721-728.
47. Lengyel P, Choubey D, Li SJ, Datta B. 1995. The interferon-activatable gene 200-cluster: from structure toward function. Semin Virol 6: 203-213.
48. Lu Q, Shen N, Li XM, Chen SL. 2007. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice. Genes Immun 8 ( 7 ): 590-603.
49. Ludlow LE, Johnstone RW, Clarke CJ. 2005. The HIN-200 family: more than interferon-inducible genes? Exp Cell Res 308 ( 1 ): 1-17.
50. Ma XY, Wang H, Ding B, Zhong H, Ghosh S, Lengyel P. 2003. The interferon-inducible p202a protein modulates NF-kappaB activity by inhibiting the binding to DNA of p50/p65 heterodimers and p65 homodimers while enhancing the binding of p50 homodimers. J Biol Chem 278 ( 25 ): 23008-23019.
51. Marshak-Rothstein A. 2006. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6 ( 11 ): 823-835.
52. McConnell BB, Vertino PM. 2004. TMS1/ASC: the cancer connection. Apoptosis 9 ( 1 ): 5-18.
53. Min W, Ghosh S, Lengyel P. 1996. The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol Cell Biol 16 ( 1 ): 359-368.
54. Moggs JG, Ashby J, Tinwell H, Lim FL, Moore DJ, Kimber I, Orphanides G. 2004. The need to decide if all estrogens are intrinsically similar. Environ Health Perspect 112 ( 11 ): 1137-1142.
55. Münz C, Lünemann JD, Getts MT, Miller SD. 2009. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9 ( 4 ): 246-258.
56. Muruve DA, Pétrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ, Tschopp J. 2008. The infl ammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 ( 7183 ): 103-107.
57. Nakai K, Kanehisa M. 1992. A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics 14 ( 4 ): 897-911.
58. Panchanathan R, Shen H, Bupp MG, Gould KA, Choubey D. 2009. Female and male sex hormones differentially regulate expression of Ifi 202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J Immunol 183 ( 11 ): 7031-7038.
59. Panchanathan R, Xin H, Choubey D. 2008. Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupusprone mice. J Immunol 180 ( 9 ): 5927-5934.
60. Petrilli V, Papin S, Tschopp J. 2005. The infl ammasome. Curr Biol 15 ( 15 ): R581.
61. Pétrilli V, Dostert C, Muruve DA, Tschopp J. 2007. The infl ammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 19 ( 6 ): 615-622.
62. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferonmediated signalling. Nat Rev Immunol 5 ( 5 ): 375-386.
63. Pramanik R, Jørgensen TN, Xin H, Kotzin BL, Choubey D. 2004. Interleukin-6 induces expression of Ifi 202, an interferoninducible candidate gene for lupus susceptibility. J Biol Chem 279 ( 16 ): 16121-16127.
64. Reed JC, Doctor K, Rojas A, Zapata JM, Stehlik C, Fiorentino L, Damiano J, Roth W, Matsuzawa S, Newman R, Takayama S, Marusawa H, Xu F, Salvesen G, Godzik A ; RIKEN GER Group; GSL Members. 2003. Comparative analysis of apoptosis and infl ammation genes of mice and humans. Genome Res 13 ( 6B ): 1376-1388.
65. Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S, Hardy LL, Garceau V, Sweet MJ, Ross IL, Hume DA, Stacey KJ. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323 ( 5917 ): 1057-1060.
66. Rozzo SJ, Allard JD, Choubey D, Vyse TJ, Izui S, Peltz G, Kotzin BL. 2001. Evidence for an interferon-inducible gene, Ifi 202, in the susceptibility to systemic lupus. Immunity 15 ( 3 ): 435-443.
67. Santiago-Raber ML, Baccala R, Haraldsson KM, Choubey D, Stewart TA, Kono DH, Theofi lopoulos AN. 2003. Type-I interferon receptor defi ciency reduces lupus-like disease in NZB mice. J Exp Med 197 ( 6 ): 777-788.
68. Schroder K, Muruve DA, Tschopp J. 2009. Innate immunity: cytoplasmic DNA sensing by the AIM2 infl ammasome. Curr Biol 19 ( 6 ): R262-R265.
69. Sen GC, Lengyel P. 1992. The interferon system. A bird's eye view of its biochemistry. J Biol Chem 267 ( 8 ): 5017-5020.
70. Stark GR, Williams BRG, Silverman RH, Schreiber RD. 1999. How cells respond to interferons? Ann Rev Biochem 67: 227-262.
71. Stehlik C, Reed JC. 2004. The PYRIN connection: novel players in innate immunity and infl ammation. J Exp Med 200 ( 5 ): 551-558.
72. Stetson DB. 2009. Connections between antiviral defense and autoimmunity. Curr Opin Immunol 21 ( 3 ): 244-250.
73. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25 ( 3 ): 373-381.
74. Theofi lopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferon (α/β) in immunity and autoimmunity. Annu Rev Immunol 23: 307-336.
75. Vilaysane A, Muruve DA. 2009. The innate immune response to DNA. Semin Immunol 21 ( 4 ): 208-214.
76. Wang C, Chatterjee G, Meyer JJ, Liu CJ, Manunath NA, Bray-Ward P, Lengyel P. 1999. Characteristics of three homologous 202 genes ( Ifi 202a, Ifi 202b, and Ifi 202c ) from the murine interferon-activatable gene 200 cluster. Genomics 60: 281-294.
77. Wen Y, Yan DH, Spohn B, Deng J, Lin SY, Hung MC. 2000. Tumor suppression and sensitization to tumor necrosis factor alphainduced apoptosis by an interferon-inducible protein, p202, in breast cancer cells. Cancer Res 60: 42-46.
78. White RJ, Jackson SP. 1992. The TATA-binding protein: a central role in transcription by RNA polymerases I, II and III. Trends Genet 8 ( 8 ): 284-288.
79. Woerner SM, Kloor M, Schwitalle Y, Youmans H, Doeberitz MK, Gebert J, Dihlmann S. 2007. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers. Genes Chromosomes Cancer 46 ( 12 ): 1080-1089.
80. Xin H, D'Souza S, Jørgensen TN, Vaughan AT, Lengyel P, Kotzin BL, Choubey D. 2006. Increased expression of Ifi 202, an IFNactivatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis. J Immunol 176 ( 10 ): 5863-5870.
81. Yamauchi M, Hashimoto M, Ichiyama K, Yoshida R, Hanada T, Muta T, Komune S, Kobayashi T, Yoshimura A. 2007. Ifi 202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells. Int Immunol 19 ( 8 ): 935-942.
82. Yan H, Dalal K, Hon BK, Youkharibache P, Lau D, Pio F. 2008. RPA nucleic acid-binding properties of IFI16-HIN200. Biochim Biophys Acta 1784 ( 7-8 ): 1087-1097.
83. Zhang K, Kagan D, DuBois W, Robinson R, Bliskovsky V, Vass WC, Zhang S, Mock BA. 2009. Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. Blood 114 ( 14 ): 2952-2960.